DNB Asset Management AS raised its holdings in CME Group Inc (NASDAQ:CME) by 2.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 42,433 shares of the financial services provider’s stock after buying an additional 1,018 shares during the quarter. DNB Asset Management AS’s holdings in CME Group were worth $7,223,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of CME. Franklin Resources Inc. bought a new stake in shares of CME Group in the 1st quarter worth approximately $237,000. BB&T Securities LLC grew its position in shares of CME Group by 41.5% in the 1st quarter. BB&T Securities LLC now owns 6,865 shares of the financial services provider’s stock worth $1,110,000 after buying an additional 2,013 shares during the last quarter. Commonwealth Equity Services LLC grew its position in shares of CME Group by 18.1% in the 1st quarter. Commonwealth Equity Services LLC now owns 28,986 shares of the financial services provider’s stock worth $4,688,000 after buying an additional 4,446 shares during the last quarter. Bayesian Capital Management LP bought a new stake in shares of CME Group in the 1st quarter worth approximately $214,000. Finally, The Manufacturers Life Insurance Company grew its position in shares of CME Group by 15.5% in the 1st quarter. The Manufacturers Life Insurance Company now owns 423,606 shares of the financial services provider’s stock worth $68,514,000 after buying an additional 56,790 shares during the last quarter. Hedge funds and other institutional investors own 84.03% of the company’s stock.
A number of equities research analysts have recently weighed in on the company. Deutsche Bank reiterated a “buy” rating and issued a $192.00 price objective (up from $185.00) on shares of CME Group in a research report on Thursday. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday. Jefferies Financial Group lifted their price objective on CME Group to $203.00 and gave the stock a “buy” rating in a research report on Monday, October 8th. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 3rd. Finally, Berenberg Bank set a $184.00 price target on CME Group and gave the company a “hold” rating in a research report on Thursday, September 20th. Five investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $178.93.
In other CME Group news, Director Ronald A. Pankau sold 260 shares of CME Group stock in a transaction on Thursday, August 9th. The stock was sold at an average price of $163.17, for a total transaction of $42,424.20. Following the completion of the transaction, the director now owns 3,900 shares in the company, valued at $636,363. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $172.30, for a total value of $51,690.00. Following the transaction, the director now owns 42,912 shares of the company’s stock, valued at approximately $7,393,737.60. The disclosure for this sale can be found here. Insiders have sold 26,688 shares of company stock worth $4,523,957 over the last 90 days. 0.43% of the stock is currently owned by corporate insiders.
NASDAQ CME opened at $176.50 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.08 and a current ratio of 1.08. CME Group Inc has a twelve month low of $132.33 and a twelve month high of $182.97. The company has a market cap of $57.79 billion, a P/E ratio of 37.00, a PEG ratio of 3.20 and a beta of 0.64.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, July 26th. The financial services provider reported $1.74 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.72 by $0.02. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the company posted $1.22 earnings per share. The firm’s revenue was up 14.6% on a year-over-year basis. Research analysts predict that CME Group Inc will post 6.64 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 25th. Investors of record on Monday, September 10th were given a dividend of $0.70 per share. The ex-dividend date of this dividend was Friday, September 7th. This represents a $2.80 annualized dividend and a dividend yield of 1.59%. CME Group’s dividend payout ratio is presently 58.70%.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Read More: How Investors Use a Balance Sheet
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.